These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Is dopamine agonist therapy associated with developing pathological gambling in Parkinson's disease patients? Zand R Eur Neurol; 2008; 59(3-4):183-6. PubMed ID: 18230877 [TBL] [Abstract][Full Text] [Related]
6. Using STN DBS and medication reduction as a strategy to treat pathological gambling in Parkinson's disease. Bandini F; Primavera A; Pizzorno M; Cocito L Parkinsonism Relat Disord; 2007 Aug; 13(6):369-71. PubMed ID: 17049455 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of pathological gambling in patients with Parkinson's disease. Avanzi M; Baratti M; Cabrini S; Uber E; Brighetti G; Bonfà F Mov Disord; 2006 Dec; 21(12):2068-72. PubMed ID: 17044068 [TBL] [Abstract][Full Text] [Related]
8. New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset. Giladi N; Weitzman N; Schreiber S; Shabtai H; Peretz C J Psychopharmacol; 2007 Jul; 21(5):501-6. PubMed ID: 17446202 [TBL] [Abstract][Full Text] [Related]
10. Pathological gambling behaviour: emergence secondary to treatment of Parkinson's disease with dopaminergic agents. Seedat S; Kesler S; Niehaus DJ; Stein DJ Depress Anxiety; 2000; 11(4):185-6. PubMed ID: 10945141 [TBL] [Abstract][Full Text] [Related]
11. Medical hazards of the internet: gambling in Parkinson's disease. Larner AJ Mov Disord; 2006 Oct; 21(10):1789. PubMed ID: 16941457 [No Abstract] [Full Text] [Related]
15. Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease. Avanzi M; Uber E; Bonfà F Neurol Sci; 2004 Jun; 25(2):98-101. PubMed ID: 15221629 [TBL] [Abstract][Full Text] [Related]
16. Pathological gambling caused by drugs used to treat Parkinson disease. Dodd ML; Klos KJ; Bower JH; Geda YE; Josephs KA; Ahlskog JE Arch Neurol; 2005 Sep; 62(9):1377-81. PubMed ID: 16009751 [TBL] [Abstract][Full Text] [Related]
17. Treatment of Parkinson's disease--where do we go from here? Suchowersky O Nat Clin Pract Neurol; 2006 Sep; 2(9):461. PubMed ID: 16932605 [No Abstract] [Full Text] [Related]
18. Dopamine agonist-triggered pathological behaviors: surveillance in the PD clinic reveals high frequencies. Hassan A; Bower JH; Kumar N; Matsumoto JY; Fealey RD; Josephs KA; Ahlskog JE Parkinsonism Relat Disord; 2011 May; 17(4):260-4. PubMed ID: 21310646 [TBL] [Abstract][Full Text] [Related]
19. Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Voon V; Hassan K; Zurowski M; Duff-Canning S; de Souza M; Fox S; Lang AE; Miyasaki J Neurology; 2006 Jun; 66(11):1750-2. PubMed ID: 16769956 [TBL] [Abstract][Full Text] [Related]
20. Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease. Pezzella FR; Colosimo C; Vanacore N; Di Rezze S; Chianese M; Fabbrini G; Meco G Mov Disord; 2005 Jan; 20(1):77-81. PubMed ID: 15390130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]